Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Renovaro Inc. - Common Stock
(NQ:
RENB
)
0.5756
-0.0294 (-4.86%)
Streaming Delayed Price
Updated: 12:26 PM EDT, Sep 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Renovaro Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
How Immunotherapy Is Cementing a Role in Cancer Treatment
November 13, 2023
Via
Investor Brand Network
Renovaro Biosciences Inc. (NASDAQ: RENB) CEO Provides Update on Combination with AI Expert GEDiCube Intl Ltd. in Letter to Shareholders
November 10, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB), GEDi Cube Combine to Transform Medicine Through AI and Biotherapeutics
November 08, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Renovaro Biosciences Inc. (NASDAQ: RENB) Announces Three New Members to Board of Directors as Definitive Agreement with GEDiCube Announced
November 06, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Derivatives
Exposures
Artificial Intelligence
Derivatives
Alarming Data Highlights Gaps in Treating People with Chronic HBV
November 01, 2023
Via
Investor Brand Network
Biotech Firms Register Successes in Quest for Better Pancreatic Cancer Treatments
October 26, 2023
Via
Investor Brand Network
Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Provides Insights on Definitive Agreement to Combine with GEDi Cube to Transform Medicine
October 23, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Scientists Find Potential to Reverse Prostate Cancer Treatment Resistance
October 20, 2023
Via
Investor Brand Network
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Participating in Webinar Focused on Future Health Tech
October 20, 2023
Via
Investor Brand Network
Why Adial Pharmaceuticals Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
October 20, 2023
Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares jumped 60.2% to $0.5101 after jumping 34% on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 20, 2023
Via
Benzinga
Everything You Need to Know About Nonreactive Hep B Screening Results
October 16, 2023
Via
Investor Brand Network
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Appoints Intel Capital Cofounder to Board
October 11, 2023
Via
Investor Brand Network
Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors
October 11, 2023
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
Patients with Metastatic Solid Tumors Have Better Outcomes After Prophylactic Radiation, Study Finds
October 10, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Strategic Board Appointments of Two Finance Industry Experts
October 10, 2023
Via
Investor Brand Network
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
October 10, 2023
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
RENOVARO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Renovaro Biosciences Inc. - RENB
October 05, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
New Prediction Model Could Slash Unnecessary Pancreatic Cancer Biopsies
October 04, 2023
Via
Investor Brand Network
Top 5 Health Care Stocks That May Plunge In October
October 04, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Releases Shareholder Letter Regarding Agreement to Combine with Leading AI Company
October 02, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD
October 02, 2023
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine
October 02, 2023
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Enters Definitive Agreement to Combine with Leading AI Tech GEDi Cube
September 29, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
RENB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Renovaro Biosciences Inc. Is Fair to Shareholders
September 29, 2023
From
Halper Sadeh LLC
Via
Business Wire
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
September 29, 2023
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
Eliminating Barriers Surrounding Solid Tumors Allows T Cells to Kill Cancerous Cells
September 28, 2023
Via
Investor Brand Network
Why Colon Cancer Is Largely Unresponsive to Immunotherapy
September 22, 2023
Via
Investor Brand Network
BioMedNewsBreaks – IBN’s BioMedWire Highlights NanoVibronix Inc.’s (NASDAQ: NAOV) $5M Private Placement
September 21, 2023
Via
Investor Brand Network
Renovaro BioSciences Inc. (NASDAQ: RENB) Targets Pancreatic Cancer Solution Through Work With GEDI Cube AI Platform, NVIDIA Resources
September 20, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.